(Q37224296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Reversal of proteinuric renal disease and the emerging role of endothelin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Matthias Barton

series ordinal

1

1 reference

19 August 2017

22 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Nephrology

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

490-501

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18648345%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Progression of chronic kidney disease: can it be prevented or arrested?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Primer: strategies for identifying genes involved in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Progression and potential regression of glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

New capillary growth: a contributor to regression of sclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Progression versus regression of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Reversal of renal disease: is it enough to inhibit the action of angiotensin II?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

The podocyte's response to injury: role in proteinuria and glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Late-Onset Endothelin-A Receptor Blockade Reduces Podocyte Injury in Homozygous Ren-2 Rats Despite Severe Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

The role of podocytes in glomerular pathobiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Proteinuria with and without renal glomerular podocyte effacement.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Glomerular podocytes contain neuron-like functional synaptic vesicles

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Urinary podocytes: lost and found alive

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocytes in culture: past, present, and future

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte differentiation and hereditary proteinuria/nephrotic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Changes in glomerular perm-selectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Regression of renal vascular fibrosis by endothelin receptor antagonism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultured rabbit synovial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Effects of endothelin-1 on thymidine uptake and fibronectin production of diabetic glomeruli

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Recent developments on endothelin antagonists as immunomodulatory drugs--from infection to transplantation medicine

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Activation of Pro-Inflammatory and Anti-Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection: Role of Endothelin Receptor Signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Functional endothelin 1 receptors on human glomerular podocytes and mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

The potential of endothelin antagonism as a therapeutic approach

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Progression of renal disease: new insights into risk factors and pathomechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Plasma and urinary endothelin-1 in focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocytes that detach in experimental membranous nephropathy are viable.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Podocyte lesions in patients with obesity-related glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Insulin infusion induces endothelin-1-dependent hypertension in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Stimulation of endothelin-1 gene expression by insulin via phosphoinositide-3 kinase-glycogen synthase kinase-3beta signaling in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Tissue- and time-dependent effects of endothelin-1 on insulin-stimulated glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Pancreatic islet transplantation. Effects on the glomerular lesions of experimental diabetes in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Renal transplantation in diabetes mellitus in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Renal protective effect of angiotensin-converting enzyme inhibition in aging rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

VEGF(165) mediates glomerular endothelial repair

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Effects of endothelin receptor antagonists on the progression of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

State-of-the-Art lecture. Role of endothelin-1 in hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Role of endothelin receptors for renal protection and survival in hypertension: waiting for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Statin-sensitive endocytosis of albumin by glomerular podocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Regression of existing glomerulosclerosis by inhibition of aldosterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Autocrine-paracrine role of endothelin-1 in the regulation of aldosterone synthase expression and intracellular Ca2+ in human adrenocortical carcinoma NCI-H295 cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Bone morphogenetic protein-7 delays podocyte injury due to high glucose

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Bmp in podocytes is essential for normal glomerular capillary formation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

Novel strategies to retard renal disease progression: combining ACE inhibition with endothelin receptor blocking?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021

What new drugs can nephrologists look forward to in the next year or two?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0891

7 January 2021